-+ 0.00%
-+ 0.00%
-+ 0.00%

NervGen Pharma Reports Positive Results from Phase 1b/2a CONNECT Study in Chronic Spinal Cord Injury

Reuters·02/11/2026 12:00:40

Please log in to view news